China is to lead a massive international research project to describe all the proteins in the human liver — the liver proteome — under the auspices of the Human Proteome Organisation (HUPO).
Controversially, as part of the project, a Beijing team hopes to generate a huge collection of monoclonal antibodies and provide them to scientists around the world at cost price. These antibodies are usually made one at a time, and HUPO is concerned both because the plan may be over-ambitious and because antibody production has not yet been standardised.
China has already pledged 200 million yuan (US$24 million) for the three-year pilot phase of the international liver-proteome study.
Reference: Nature 425, 441 (2003)